The year in asthma

P. Chanez (Marseille, France)

Source: International Congress 2018 – Clinical Year in Review
Session: Clinical Year in Review
Session type: Year in review
Number: 2094
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Chanez (Marseille, France). The year in asthma. International Congress 2018 – Clinical Year in Review

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The incidence of asthma and allergic rhinitis among young adults in 12 year follow-up
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


A ten year follow-up of former paediatric asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 233s
Year: 2005

Mothers pollen exposure and hospitalization for asthma during first year of life
Source: Eur Respir J 2002; 20: Suppl. 38, 147s
Year: 2002

COPD exacerbation phenotypes in a five year hospitalisation cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

The prognosis of childhood asthma, 10 year follow-up
Source: Eur Respir J 2005; 26: Suppl. 49, 452s
Year: 2005

Effect of allergic rhinitis on asthma-related hospitalization, GP visit and drug cost among adult asthmatic patients in the UK
Source: Eur Respir J 2002; 20: Suppl. 38, 396s
Year: 2002

Emergency visits for asthma: asthma exacerbations or poor asthma control?
Source: Eur Respir J 2004; 24: Suppl. 48, 598s
Year: 2004

Living with severe asthma year 2016
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Omalizumab in severe uncontrolled asthma: two and a half year clinical experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009


Characteristics of severe asthma in China with one year follow-up: the C-BIOPRED study
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019


Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece.
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


The effect of month of birth on the prevalence rates of asthma, hay fever and eczema in children
Source: Eur Respir J 2005; 26: Suppl. 49, 380s
Year: 2005

The course of asthma in preschool children with asthma
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019

Asthma, wheeze and cough in 7 to 9 year old schoolchildren
Source: Eur Respir J 2001; 18: Suppl. 33, 286s
Year: 2001

Gender differences in allergic and non-allergic asthma over 20 years of follow-up
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017

Development of asthma and atopic dermatitis in school children who use antibiotics in the first year of life
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006


Social class in asthma and allergic rhinitis: a national cohort study over three decades
Source: Eur Respir J 2005; 26: 1064-1068
Year: 2005